128 related articles for article (PubMed ID: 27053336)
1. Piperlongumine inhibits gastric cancer cells via suppression of the JAK1,2/STAT3 signaling pathway.
Song B; Zhan H; Bian Q; Gu J
Mol Med Rep; 2016 May; 13(5):4475-80. PubMed ID: 27053336
[TBL] [Abstract][Full Text] [Related]
2. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
[TBL] [Abstract][Full Text] [Related]
3. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer.
Chen D; Ma Y; Li P; Liu M; Fang Y; Zhang J; Zhang B; Hui Y; Yin Y
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242627
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
6. Amorfrutin A inhibits TNF-α induced JAK/STAT signaling, cell survival and proliferation of human cancer cells.
Mi C; Ma J; Wang KS; Wang Z; Li MY; Li JB; Li X; Piao LX; Xu GH; Jin X
Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):338-347. PubMed ID: 28879797
[TBL] [Abstract][Full Text] [Related]
7. Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway.
Lu YM; Chen W; Zhu JS; Chen WX; Chen NW
Mol Med Rep; 2016 Mar; 13(3):2235-40. PubMed ID: 26795301
[TBL] [Abstract][Full Text] [Related]
8. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
9. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
10. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
12. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
[TBL] [Abstract][Full Text] [Related]
13. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
Bharadwaj U; Eckols TK; Kolosov M; Kasembeli MM; Adam A; Torres D; Zhang X; Dobrolecki LE; Wei W; Lewis MT; Dave B; Chang JC; Landis MD; Creighton CJ; Mancini MA; Tweardy DJ
Oncogene; 2015 Mar; 34(11):1341-53. PubMed ID: 24681959
[TBL] [Abstract][Full Text] [Related]
14. Stromal Lkb1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11-JAK/STAT3 pathway.
Ollila S; Domènech-Moreno E; Laajanen K; Wong IP; Tripathi S; Pentinmikko N; Gao Y; Yan Y; Niemelä EH; Wang TC; Viollet B; Leone G; Katajisto P; Vaahtomeri K; Mäkelä TP
J Clin Invest; 2018 Jan; 128(1):402-414. PubMed ID: 29202476
[TBL] [Abstract][Full Text] [Related]
15. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin.
Yao X; Li G; Xu H; Lü C
Planta Med; 2012 Nov; 78(16):1740-8. PubMed ID: 22961117
[TBL] [Abstract][Full Text] [Related]
17. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway.
Huang Y; Zhang J; Wang G; Chen X; Zhang R; Liu H; Zhu J
Int J Immunopathol Pharmacol; 2018; 32():2058738418781634. PubMed ID: 30103640
[TBL] [Abstract][Full Text] [Related]
18. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
19. Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer.
Jo MJ; Jeong S; Yun HK; Kim DY; Kim BR; Kim JL; Na YJ; Park SH; Jeong YA; Kim BG; Ashktorab H; Smoot DT; Heo JY; Han J; Lee DH; Oh SC
BMC Cancer; 2019 Jul; 19(1):739. PubMed ID: 31351462
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
